Our Bureau, New Delhi Monday, March 10, 2025, 17:10 Hrs [IST] The Department of Pharmaceuticals (DoP) has released the Expre ...
Nona Biosciences to unveil its innovative AI-assisted drug discovery engine, Hu-mAtrIx: Cambridge, Massachusetts Monday, March 10, 2025, 17:00 Hrs [IST] Nona Biosciences, a global ...
SS Innovations unveils India’s first mobile tele-surgical unit, MantraM at SMRSC 2025: Our Bureau, Bengaluru Monday, March 10, 2025, 16:45 Hrs [IST] SS Innovations, the maker of ...
L V Prasad Eye Institute highlights eye cancer is rare but serious threat that needs more awareness. Most people associate cancer with the lungs, breast, or skin, but few realize that cancer can also ...
European Commission approves Bristol Myers Squibb’s Opdivo plus Yervoy for first-line treatment of adult patients with unresectable or advanced HCC: Princeton, New Jersey Monday ...
AstraZeneca Pharma India gets CDSCO nod for durvalumab to treat LS-SCLC: Our Bureau, Bengaluru Monday, March 10, 2025, 15:30 Hrs [IST] AstraZeneca Pharma India, received a Central ...
Montpellier, France Monday, March 10, 2025, 15:00 Hrs [IST] ...
Glenmark Therapeutics launches polyethylene glycol 3350, powder for solution, 17 grams/capful in US: Our Bureau, Mumbai Monday, March 10, 2025, 14:15 Hrs [IST] Glenmark Therapeuti ...
National Institutes of Health centralizes peer review to improve efficiency and strengthen integrity
National Institutes of Health centralizes peer review to improve efficiency and strengthen integrity: Bethesda, Maryland Monday, March 10, 2025, 14:00 Hrs [IST] The National Insti ...
Mpower’s data on women’s challenges reveal women’s mental health in crisis: Our Bureau, Mumbai Monday, March 10, 2025, 13:45 Hrs [IST] Women’s mental health is in crisis.
Sun Pharma to acquire Waltham, Massachusetts-based Checkpoint Therapeutics: Our Bureau, Mumbai Monday, March 10, 2025, 13:30 Hrs [IST] Sun Pharmaceutical Industries Limited and Ch ...
Full Circles gets US patent titled “Targeted Genome Modification Using Circular Single-Stranded DNA”
Full Circles Therapeutics, a leader in next-generation genome engineering, announces that the United States Patent and Trademark Office (USPTO) has allowed its foundational patent titled "Targeted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results